584 related articles for article (PubMed ID: 26506908)
1. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
[TBL] [Abstract][Full Text] [Related]
2. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
[TBL] [Abstract][Full Text] [Related]
3. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
4. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
[TBL] [Abstract][Full Text] [Related]
5. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
6. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
Gurbuz C; Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
J Endourol; 2011 May; 25(5):775-9. PubMed ID: 21388245
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
Gakis G; Fritsche HM; Hassan F; Kluth L; Miller F; Soave A; Otto W; Schwentner C; Todenhöfer T; Dahlem R; Burger M; Fisch M; Stenzl A; Aziz A; Rink M
Eur J Cancer; 2014 Oct; 50(15):2583-91. PubMed ID: 25088206
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Nakajima Y; Oya M
Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
[TBL] [Abstract][Full Text] [Related]
12. TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.
Youssef RF; Krabbe LM; Shariat SF; Lotan Y; Sagalowsky AI; Raman J; Wood CG; Weizer A; Roscigno M; Montorsi F; Bolenz C; Remzi M; Bensalah K; Kassouf W; Margulis V
World J Urol; 2015 Dec; 33(12):1965-72. PubMed ID: 25957592
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
[TBL] [Abstract][Full Text] [Related]
15. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.
Shariat SF; Favaretto RL; Gupta A; Fritsche HM; Matsumoto K; Kassouf W; Walton TJ; Tritschler S; Baba S; Matsushita K; Bastian PJ; Martínez-Salamanca JI; Seitz C; Pycha A; Otto W; Karakiewicz PI; Ficarra V; Novara G
World J Urol; 2011 Aug; 29(4):481-6. PubMed ID: 20886219
[TBL] [Abstract][Full Text] [Related]
17. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
Raman JD; Lin YK; Kaag M; Atkinson T; Crispen P; Wille M; Smith N; Hockenberry M; Guzzo T; Peyronnet B; Bensalah K; Simhan J; Kutikov A; Cha E; Herman M; Scherr D; Shariat SF; Boorjian SA
Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
[TBL] [Abstract][Full Text] [Related]
18. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
Burger M; Shariat SF; Fritsche HM; Martinez-Salamanca JI; Matsumoto K; Chromecki TF; Ficarra V; Kassouf W; Seitz C; Pycha A; Tritschler S; Walton TJ; Novara G
World J Urol; 2011 Aug; 29(4):465-72. PubMed ID: 21630120
[TBL] [Abstract][Full Text] [Related]
19. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Aziz A; Rink M; Gakis G; Kluth LA; Dechet C; Miller F; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Fisch M; Burger M; Fritsche HM
Urol Int; 2014; 93(3):352-60. PubMed ID: 25138778
[TBL] [Abstract][Full Text] [Related]
20. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
Youssef RF; Lotan Y; Sagalowsky AI; Shariat SF; Wood CG; Raman JD; Langner C; Zigeuner R; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
Int Braz J Urol; 2013; 39(5):614-21. PubMed ID: 24267122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
